> ## Content Index
> Fetch the complete content index at: https://intelligence.wildlandseco.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Outbreak genomics can narrow antibody hypotheses before it can establish treatment efficacy
- URL: https://intelligence.wildlandseco.com/2026-09-27-bundibugyo-antibody-genomic-screen/
- Published: 2026-09-27T11:16:15.000Z
- Updated: 2026-09-27T11:16:15.000Z
- Author: Benjamin Worlund
- Tags: Bundibugyo virus, Ebola antibodies, outbreak genomics, One Health, Disease, Genomics, Methods, #ecological-intelligence, #brief-2026-09-27, #global-radar, #peer-reviewed, #geo-africa

Evidence

Peer-reviewed

Geography

Democratic Republic of the Congo and Uganda

System

Bundibugyo virus outbreak / One Health disease system

## WHAT THE EVIDENCE SAYS

Researchers analyzed 44 Bundibugyo virus sequences, including 12 from the 2026 outbreak, and used genomic and structural analyses to assess how existing Ebola monoclonal antibodies may bind the outbreak glycoprotein.

## WHY IT MATTERS / OUR READ

Rapid genomic analysis can prioritize which countermeasures deserve laboratory and clinical attention during an outbreak, shortening the hypothesis space before definitive efficacy evidence exists.

## CAVEATS / UNCERTAINTY

The paper predicts antibody binding and potential efficacy; it does not demonstrate clinical effectiveness in patients. The published version is an early peer-reviewed article that remains subject to editorial replacement by the final version of record.

## SOURCE

Nature Communications  
[View original evidence ↗](https://www.nature.com/articles/s41467-026-78077-9?ref=intelligence.wildlandseco.com)

From the Morning Brief · 2026-09-27

[Read the full Morning Brief →](https://intelligence.wildlandseco.com/morning-brief-2026-09-27/)